M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Organon & Co. to acquire Dermavant
Announced Oct 28, 2024 · Closed Oct 28, 2024 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Organon & Co. (OGN)
- Target
- Dermavant
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Oct 28, 2024
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations